×

Entellus Medical to Present at the Canaccord Genuity Growth Conference

PLYMOUTH, Minn., July 27, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced the company plans to participate in the 36th Annual Growth Conference hosted by Canaccord Genuity in Boston, MA.

Entellus Medical’s management is scheduled to present on Wednesday, August 10, 2016 at 12:00pm ET. Interested parties can access the live audio webcast at http://www.entellusmedical.com. An archived presentation will be available on the website.

About Entellus Medical, Inc.
Entellus Medical is a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. The Entellus Medical platform of products provide effective and easy-to-use solutions to simplify everything from diagnosis and patient selection, to complex case revisions and post-operative care. Entellus Medical’s three core product lines, XprESS™ Multi-Sinus Dilation Systems, MiniFESS™ Surgical Instruments, and FocESS™ Imaging & Navigation, combine to enable ENT physicians to conveniently and comfortably perform a broad range of procedures in the office and simplify OR based treatment. Entellus Medical is committed to broadening its product portfolios with high-quality and purposeful innovations for the global ENT market. For more information, please visit the Company's website at www.entellusmedical.com.

Contact: Lynn Pieper Lewis 415-937-5402 ir@entellusmedical.com

Source:Entellus Medical, Inc.